CS
LHDX

Clear Street’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Clear Street’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,000
Closed -$230 – 1609
2023
Q1 		$230 Buy
+1,000
New +$356 ﹤0.01% 1068

Other funds holding LHDX

RA
Resolute Advisors San Francisco, California $417M AUM 60.99% 1-Year Est. Return

Clear Street's LHDX Position: Q2 2023 in Review

Clear Street sold out of Lucira Health, Inc. Common Stock (LHDX) in Q2 2023, closing a stake of 1,000 shares — an estimated $230 sold.

Clear Street first reported a position in LHDX in Q1 2023 and held it in 1 quarter. The position peaked at $230 in Q1 2023. 1 fund tracked by Wall St. Rank holds LHDX as of Q2 2023.

  • Clear Street reported no remaining Lucira Health, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Clear Street sold 1,000 Lucira Health, Inc. Common Stock shares in Q2 2023, an estimated $230.
  • Clear Street first reported a position in Lucira Health, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Clear Street's Lucira Health, Inc. Common Stock position peaked at $230 in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q2 2023.

Based on Clear Street's 13F filing for Q2 2023, filed 14 Aug 2023.